545 - First-in-human total-body PET imaging of HIV with 89Zr-VRC01 on the EXPLORER (ID 357) - Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting

545 - First-in-human total-body PET imaging of HIV with ⁸⁹Zr-VRC01 on the EXPLORER (ID 357)

General Clinical Specialties -> Outcomes/Infections Disease/Pulmonary 545

545 - First-in-human total-body PET imaging of HIV with ⁸⁹Zr-VRC01 on the EXPLORER (ID 357)

Session Name

Infection/Pulmonary/Outcomes

Speakers

D. Beckford Vera

Authors

Presentation Topic

General Clinical Specialties -> Outcomes/Infections Disease/Pulmonary

Presentation Number

545

Previous Eposter

544 - ⁶⁸Ga-FAPI PET/CT for imaging of fibrosis in IgG4-related disease: comparison to ¹⁸F-FDG PET/CT (ID 359)

Next Eposters

546 - HER3 as a Predictor of Response to Neoadjuvant Therapy in Breast Cancer patients. A Clinical Study (ID 839)

547 - Kinetic modeling of [¹⁸F]FES PET in patients with metastatic ER+ breast cancer (ID 840)

550 - Prognostic values of quantitative and morphological parameters of dbPET in patients with luminal-type breast cancer: A pilot study (ID 843)

551 - Reproducibility of uptake on dedicated breast PET and its diagnostic impact (ID 844)

554 - F-18 FDG PET/MRI IN PRIMARY STAGING OF BREAST CANCER: THE RELATIONSHIPS BETWEEN IMAGING PARAMETERS OF PRIMARY TUMOR AND DISTANT METASTASES (ID 845)

555 - Radiomics features of ¹⁸F-FDG PET/CT predicting breast cancer molecular subtype: a preliminary study (ID 846)

556 - ^99mTc-HPArk2 SPECT/CT in the evaluation of HER2-positive breast cancer: a pilot prospective study (ID 847)

558 - Intra-tumor metabolic heterogeneity of gastric cancer on¹⁸F-FDG PETCT indicates patient survival outcomes (ID 703)

559 - The relationship of the standard uptake value between the patients with the primary hepatic neoplasm and secondary hepatic neoplasm:A study of PET-CT scans (ID 709)

560 - Efficacy of 4DST-PET/CT for predicting the prognosis in patients with esophageal cancer: a comparison study with FDG-PET/CT (ID 704)